Portfolio News

Accolade Secures $70 Million in Series E Funding

Health concierge Accolade raised $70 million in investment funding. The start-up company will use the funding to expand its outreach efforts, which include: marketing, sales, research, and further developing its technological platform. Private American venture capital firm Andreessen Horowitz led the fundraising efforts, with significant contributions from Madrona Venture Group. Jeff Jordan, Andreessen Horowitz General Partner, is now serving on Accolade’s board of directors. "Accolade is simply the best tool we’ve seen to help companies simultaneously improve both the quality and the cost of health care,” Jordan...

PillPack Deploys PokitDok’s Pharmacy APIs for Real-Time Pharmacy Eligibility

PokitDok and PillPack are partnering up to improve patient experiences for more than 16 million Medicare Advantage Beneficiaries and 40.5 million Medicare Part D Prescription Drug Benefit Plan recipients. PokitDok, a McKesson Ventures portfolio company, is a cloud-based API platform that is designed to streamline healthcare transactions. By partnering with PokitDok, PillPack enables its customers to instantly find out which prescriptions are covered, how much it costs, and how their insurance applies. PillPack primarily serves individuals that must manage multiple medications, making the process simpler by delivering...

Playing catch-up in hospital innovation

In a recent article on TechCrunch, Crunch Network contributor Mandira Singh argues that a big change is due in health care: more tech innovations to improve processes, deliver healthcare, increase accuracy, and ensure that patients are able to receive the care they need, when they need it. While we have over a million apps and other services to help us stay fit, keep us entertained, educate us, improve our efficiency, and more, the healthcare industry is notably lacking in IT solutions. Yet these are the kinds...

Health Systems’ Integrated Virtual Clinics Improve Care Quality

In an article for Health IT Outcomes, Christine Kern explains how commercial telemedicine providers fall short in key quality measures—while integrated telemedicine services provide better continuity of care and meet the highest quality care delivery benchmarks. Kern’s claims are supported by a number of sources, including a study from McKesson Ventures portfolio company Carena. The Carena study revealed that patients also receive more time with clinicians and have lower prescription rates when using integrated telemedicine services versus commercial telemedicine providers. A supporting infographic from Carena, “3 Ways...